Genworth Financial (GNW) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Dec, 2025Executive summary
Net income for Q1 2025 was $54 million ($0.13 per diluted share), with adjusted operating income of $51 million ($0.12 per diluted share), primarily driven by Enact's $137 million contribution and $76 million in capital returns.
Enact announced a 14% dividend increase, a $350 million share repurchase authorization, and was added to the S&P Small Cap 600 Index.
CareScout expanded its Quality Network to cover 90% of the U.S. 65+ population, delivering 576 matches in Q1 and receiving inaugural LTC product approval from the Insurance Compact.
The company continues to focus on value creation through Enact, maintaining self-sustaining legacy insurance, and scaling CareScout's aging care services.
Share repurchases totaled $45 million in Q1 2025 ($590 million since inception), with $110 million remaining authorized.
Financial highlights
Q1 2025 adjusted operating income was $51 million, with Enact as the main contributor; net income was $54 million, down from $139 million in Q1 2024.
Long-term care insurance segment reported a $30 million adjusted operating loss, and life and annuities had a $33 million loss, both impacted by high mortality and lower investment income.
Corporate and Other reported a $23 million loss, improved from $38 million loss in the prior year due to non-recurring tax timing.
Total revenues for Q1 2025 were $1.79 billion, down 4% year-over-year; net investment income was $739 million, down 5% year-over-year.
Genworth ended Q1 with $211 million in cash and liquid assets.
Outlook and guidance
Enact expects to return similar levels of capital to shareholders in 2025 as in 2024, with a new $350 million share repurchase authorization.
The company plans to invest $45–$50 million in CareScout Services and $75 million in CareScout Insurance in 2025.
CareScout's new insurance product is on track for launch in the second half of 2025, targeting approvals in 30–35 states.
Management expects continued volatility in long-term care insurance results due to assumption updates and experience variances.
Latest events from Genworth Financial
- Disciplined strategy, board oversight, and ESG focus delivered strong shareholder value in 2025.GNW
Proxy filing23 Apr 2026 - Shareholders to vote on directors, pay, stock plan, and auditor amid strong performance and governance.GNW
Proxy filing6 Apr 2026 - Key votes include director elections, executive pay, stock plan, and auditor ratification.GNW
Proxy filing6 Apr 2026 - Proxy details 2025 performance, capital returns, and key votes on directors, pay, and auditor.GNW
Proxy filing24 Mar 2026 - Enact drove Q4 profits and capital returns; CareScout expanded as LTC losses weighed on results.GNW
Q4 202524 Feb 2026 - Q2 2024 adjusted operating income rose to $125M, driven by Enact and strong capital returns.GNW
Q2 20242 Feb 2026 - Q3 net income rose to $85M, driven by Enact strength, LTC actions, and CareScout growth.GNW
Q3 202415 Jan 2026 - Q4 net loss of $1M, strong Enact results, and $565M in share repurchases amid LTC headwinds.GNW
Q4 202421 Dec 2025 - Shareholders to vote on board, pay, incentive plan, auditor, and governance changes after a strong year.GNW
Proxy Filing1 Dec 2025